Evidence map›Paper›PMID 22436981›Full record

ArticleEuropean journal of cancer (Oxford, England : 1990)2012

Increased risk of lung cancer in individuals with a family history of the disease: a pooled analysis from the International Lung Cancer Consortium.

Michele L Coté, Mei Liu, Stefano Bonassi, Monica Neri, Ann G Schwartz, David C Christiani, Margaret R Spitz, Joshua E Muscat, Gad Rennert, Katja K Aben and 49 more

2 registry-linked trialsOpen access · bronzeAbstract read
In one paragraph

Article in European journal of cancer (Oxford, England : 1990), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 96 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
96citing papers in PubMed, 4 pooled it
7.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02519972 nacompletednot on this map

Low-dose Computed Tomography Screening for Lung Cancer in Relatives With Family History of Lung Cancer

TypeinterventionalSponsorTaichung Veterans General HospitalRan2007 to 2011Enrolled1,102ConditionsLung CancerArmslow dose computed tomography
NCT05762731 recruitingnot on this mapstarted 2023, after this paper: background citation

Screening for Lung Cancer in Subjects With Family History of Lung Cancer

Typeobservational_patient_registrySponsorThe University of Hong KongRan2023 to 2028Enrolled1,520ConditionsLung CancerArmsLow dose CT thorax
3 · Its place in the literature

Who cites it

96 citing papers in PubMed, 4 syntheses or guidelines pooled it, 202 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Article
  7. Article
  8. International journal of molecular sciences · 2026
    Review
  9. Article
  10. High-Penetrance Rare Variants Underlying Familial Lung Cancer Risk: Insights From Genetic Epidemiology of Lung Cancer Consortium.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review

36 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

59 authors at 20 institutions in 18 countries.

Michele L CotéWayne State University School of Medicine and the Karmanos Cancer Institute, Michigan, USA. cotem@karmanos.org
Mei Liu
Stefano Bonassi
Monica Neri
Ann G Schwartz
David C Christiani
Margaret R Spitz
Joshua E Muscat
Gad Rennert
Katja K Aben
Angeline S Andrew
Vladimir Bencko
Heike Bickeböller
Paolo Boffetta
Paul Brennan
Hermann Brenner
Eric J Duell
Eleonora Fabianova
John K Field
Lenka Foretova
Søren Friis
Curtis C Harris
Ivana Holcatova
Yun-Chul Hong
Dolores Isla
Vladimir Janout
Lambertus A Kiemeney
Chikako Kiyohara
Qing Lan
Philip Lazarus
Jolanta Lissowska
Loic Le Marchand
Dana Mates
Keitaro Matsuo
Jose I Mayordomo
John R McLaughlin
Hal Morgenstern
Heiko Müeller
Irene Orlow
Bernard J Park
Mila Pinchev
Olaide Y Raji
Hedy S Rennert
Peter Rudnai
Adeline Seow
Isabelle Stucker
Neonila Szeszenia-Dabrowska
M Dawn Teare
Anne Tjønnelan
Donatella Ugolini
Henricus F M van der Heijden
Erich Wichmann
John K Wiencke
Penella J Woll
Ping Yang
David Zaridze
Zuo-Feng Zhang
Carol J Etzel
Rayjean J Hung
Technion – Israel Institute of Technology · ILThe University of Texas MD Anderson Cancer Center · USCharles University · CZDanish Cancer Society · DKGerman Cancer Research Center · DEInserm · FRIRCCS Ospedale San Raffaele · ITMount Sinai Hospital · CANational Cancer Institute · USNofer Institute of Occupational Medicine · PLPennsylvania State University · USRadboud University Nijmegen · NLUniversidad de Zaragoza · ESUniversity of Liverpool · GBWayne State University · USAichi Cancer Center · JPCentre international de recherche sur le cancer · FRDartmouth College · USHackensack University Medical Center · USHarvard University · US

Funding

Tumor Biology and Microenvironment (Program 1)P30CA022453 · NCI · WAYNE STATE UNIVERSITY · PI PAUL M STEMMER · 1985 to 2026
$68.4M
Translational studies of Hsp90 inhibitors in NSCLCP50CA090578 · NCI · DANA-FARBER CANCER INST · PI JOHNSON, BRUCE D · 2008 to 2012
$11.4M
Integrative Molecular Epidemiology of Human CancerZIABC011495 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HARRIS, CURTIS · 2013 to 2019
$9.5M
GENETIC EPIDEMIOLOGY OF LUNG CANCERR01CA060691 · NCI · WAYNE STATE UNIVERSITY · PI SCHWARTZ, ANN G. · 1995 to 2009
$6.2M
Molecular and Genetic Analysis of Lung Cancer SurvivalR01CA092824 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI CHRISTIANI, DAVID C · 2002 to 2013
$5.9M
GENETIC SUSCEPTIBILITY TO LUNG CANCERR01CA074386 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI CHRISTIANI, DAVID C · 1997 to 2008
$4.8M
Molecular Epidemiology of Human Lung CancerZIABC005480 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HARRIS, CURTIS · 2009 to 2012
$3.0M
Adenocarinoma of the Lung in WomenR01CA087895 · NCI · WAYNE STATE UNIVERSITY · PI SCHWARTZ, ANN G · 2001 to 2005
$3.0M
Biomarkers of Human Lung CancerZIABC010874 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HARRIS, CURTIS · 2009 to 2012
$2.9M
Enhancing neoadjuvant chemotherpay responses with targeted T cellsR01CA140314 · NCI · WAYNE STATE UNIVERSITY · PI BEPLER, GEROLD · 2010 to 2015
$2.5M
Exploring Common Linkage Regions in Lung Cancer and COPDK07CA125203 · NCI · WAYNE STATE UNIVERSITY · PI COTE, MICHELE L. · 2008 to 2012
$772k
NCI NIH HHS K07 CA125203NCI NIH HHS N01 PC035145NCI NIH HHS N01-PC35145NCI NIH HHS P30 CA022453NCI NIH HHS P30CA22453NCI NIH HHS P50 CA090578NCI NIH HHS R01 CA060691NCI NIH HHS R01CA060691NCI NIH HHS R01 CA074386NCI NIH HHS R01 CA087895NCI NIH HHS R01 CA092824NCI NIH HHS R01 CA140314NCI NIH HHS R01CA74386NCI NIH HHS R01CA87895
6 · The paper itself

Abstract

BACKGROUND AND

methodsFamilial aggregation of lung cancer exists after accounting for cigarette smoking. However, the extent to which family history affects risk by smoking status, histology, relative type and ethnicity is not well described. This pooled analysis included 24 case-control studies in the International Lung Cancer Consortium. Each study collected age of onset/interview, gender, race/ethnicity, cigarette smoking, histology and first-degree family history of lung cancer. Data from 24,380 lung cancer cases and 23,305 healthy controls were analysed. Unconditional logistic regression models and generalised estimating equations were used to estimate odds ratios and 95% confidence intervals.

resultsIndividuals with a first-degree relative with lung cancer had a 1.51-fold increase in the risk of lung cancer, after adjustment for smoking and other potential confounders (95% CI: 1.39, 1.63). The association was strongest for those with a family history in a sibling, after adjustment (odds ratios (OR) = 1.82, 95% CI: 1.62, 2.05). No modifying effect by histologic type was found. Never smokers showed a lower association with positive familial history of lung cancer (OR = 1.25, 95% CI: 1.03, 1.52), slightly stronger for those with an affected sibling (OR = 1.44, 95% CI: 1.07, 1.93), after adjustment.

conclusionsThe occurrence of lung cancer among never smokers and similar magnitudes of the effect of family history on lung cancer risk across histological types suggests familial aggregation of lung cancer is independent of those risks associated with cigarette smoking. While the role of genetic variation in the aetiology of lung cancer remains to be fully characterised, family history assessment is immediately available and those with a positive history represent a higher risk group.

Indexed as

Family HealthGenetic Predisposition to DiseaseAdultAgedAged, 80 and overAge FactorsCase-Control StudiesEthnicityFemaleHumansLung NeoplasmsMaleMiddle AgedRisk FactorsSiblingsSmoking

Identifiers

PMID22436981
PMCPMC3445438
OpenAlexW2157334646

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.